Award Year / Program / Phase:2009 / SBIR / Phase I
Agency:HHS
Principal Investigator:James D. Thacker
Award Amount:$636,492.00
Abstract:
DESCRIPTION (provided by applicant): The product that will result from this proposal will be a potent biological regulator of innate immunity, 1- peptidyl-2,3-diacylglyceride (PDAG), for use in the prevention of hospital-acquired (nosocomial) infections i
n highly-susceptible patient populations.… More